Showing 1 - 20 of 82 Results
Limited Interaction Targeted Epidemiology (LITE-2): To Advance HIV Prevention (UG3/UH3 Clinical Trial Optional)
FOA Number
Release Date
Expiration Date
Activity Code(s)
Clinical Trials
Categories
Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium (U01 Clinical Trial Not Allowed)
FOA Number
Release Date
Expiration Date
Activity Code(s)
Clinical Trials
Notice of Special Interest (NOSI): Identification of Biomarkers of HIV Pathogenesis and Substance Use Disorder Comorbidity
FOA Number
Release Date
Expiration Date
Clinical Trials
Organizations
Categories
Respond: Epidemiology to End the HIV Epidemic (RESPOND: EEE) (R01 Clinical Trial Optional)
FOA Number
Release Date
Expiration Date
Activity Code(s)
Clinical Trials
Prevention Strategies to End the HIV Epidemic (R01 Clinical Trial Optional)
FOA Number
Release Date
Expiration Date
Activity Code(s)
Clinical Trials
Multidisciplinary Treatment Approaches to End the HIV Epidemic (R01 Clinical Trial Optional)
FOA Number
Release Date
Expiration Date
Activity Code(s)
Clinical Trials
Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 Clinical Trial Optional)
FOA Number
Release Date
Expiration Date
Activity Code(s)
Clinical Trials
Organizations
Categories
Notice of Special Interest (NOSI): Medical Consequences of Smoking and Vaping Drugs of Abuse in Individuals with HIV and COVID-19
FOA Number
Release Date
Expiration Date
Clinical Trials
Organizations
Notice of Special Interest (NOSI): Long-Term Neurocognitive Consequences of COVID-19 in Individuals Living with HIV and Substance Use Disorders
FOA Number
Release Date
Expiration Date
Clinical Trials
Organizations
Categories
Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R61/R33 - Clinical Trial Not Allowed)
FOA Number
Release Date
Expiration Date
Activity Code(s)
Clinical Trials
Organizations
Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection
FOA Number
Release Date
Expiration Date
Clinical Trials
Organizations
Notice of Special Interest (NOSI): Aging-Relevant Behavioral and Social Research on Coronavirus Disease 2019 (COVID-19)
FOA Number
Release Date
Expiration Date
Clinical Trials
Organizations
Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)
FOA Number
Release Date
Expiration Date
Activity Code(s)
Clinical Trials
Organizations
Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of the NIDDK (R21 Clinical Trial Not Allowed)
FOA Number
Release Date
Expiration Date
Activity Code(s)
Clinical Trials
Organizations
Priority HIV/AIDS Research within the Mission of the NIDDK (R01 Clinical Trial Optional)
FOA Number
Release Date
Expiration Date
Activity Code(s)
Clinical Trials
Organizations
Notice of Special Interest: Alcohol-induced Tissue-specific and Organ System Diseases (R01/R21/R03)
FOA Number
Release Date
Expiration Date
Clinical Trials
Organizations
Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities
FOA Number
Release Date
Expiration Date
Activity Code(s)
Clinical Trials
Addressing Health Disparities among Immigrant Populations through Effective Interventions (R01 Clinical Trial Optional)
FOA Number
Release Date
Expiration Date
Activity Code(s)
Clinical Trials
Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01 Clinical trial not allowed)
FOA Number
Release Date
Expiration Date
Activity Code(s)
Clinical Trials
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional)
FOA Number
Release Date
Expiration Date
Activity Code(s)
Clinical Trials